ID: ALA2431070

Max Phase: Preclinical

Molecular Formula: C26H33N3O7S

Molecular Weight: 531.63

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)C1=C(S[C@@H]2CN[C@H](C(=O)Nc3cccc(C(=O)OCC)c3)C2)[C@H](C)[C@@H]2[C@@H]([C@@H](C)O)C(=O)N12

Standard InChI:  InChI=1S/C26H33N3O7S/c1-5-35-25(33)15-8-7-9-16(10-15)28-23(31)18-11-17(12-27-18)37-22-13(3)20-19(14(4)30)24(32)29(20)21(22)26(34)36-6-2/h7-10,13-14,17-20,27,30H,5-6,11-12H2,1-4H3,(H,28,31)/t13-,14-,17+,18+,19-,20-/m1/s1

Standard InChI Key:  GVMSLNANKYADKT-PGTOZNMBSA-N

Associated Targets(Human)

Liver microsomes 16955 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hepatocyte 2737 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 7708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver microsomes 8692 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 280 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 810 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Canis familiaris 36305 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

LLC-PK1 2135 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hepatocyte 2621 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 10718 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 531.63Molecular Weight (Monoisotopic): 531.2039AlogP: 1.90#Rotatable Bonds: 9
Polar Surface Area: 134.27Molecular Species: BASEHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.98CX Basic pKa: 8.99CX LogP: 1.01CX LogD: -0.59
Aromatic Rings: 1Heavy Atoms: 37QED Weighted: 0.32Np Likeness Score: 0.00

References

1. Singh SB, Rindgen D, Bradley P, Cama L, Sun W, Hafey MJ, Suzuki T, Wang N, Wu H, Zhang B, Wang L, Ji C, Yu H, Soll R, Olsen DB, Meinke PT, Nicoll-Griffith DA..  (2013)  Design, synthesis, and evaluation of prodrugs of ertapenem.,  (8): [PMID:24900737] [10.1021/ml400092n]
2. Singh SB, Rindgen D, Bradley P, Suzuki T, Wang N, Wu H, Zhang B, Wang L, Ji C, Yu H, Soll RM, Olsen DB, Meinke PT, Nicoll-Griffith DA..  (2014)  Design, synthesis, structure-function relationship, bioconversion, and pharmacokinetic evaluation of ertapenem prodrugs.,  57  (20): [PMID:25265501] [10.1021/jm500879a]

Source